CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Losses	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2023		97,377,121
Beginning balance at Dec. 31, 2023	$ 133,071	$ 2	$ 624,414	$ (15)	$ (491,330)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock (in shares)		22,560,001
Issuance of common stock	132,055		132,055
Issuance of pre-funded warrants, net of issuance costs of $1.2 million	18,800		18,800
Issuances of common stock under the employee stock purchase plan (in shares)		74,488
Issuances of common stock under the employee stock purchase plan	436		436
Issuance of common stock upon exercise of stock options (in shares)		9,664
Issuance of common stock upon exercise of stock options	36		36
Stock-based compensation expense	5,209		5,209
Change in unrealized loss on investments, net of tax	(80)			(80)
Net loss	(45,761)				(45,761)
Ending balance (in shares) at Mar. 31, 2024		120,021,274
Ending balance at Mar. 31, 2024	243,766	$ 2	780,950	(95)	(537,091)
Beginning balance (in shares) at Dec. 31, 2023		97,377,121
Beginning balance at Dec. 31, 2023	133,071	$ 2	624,414	(15)	(491,330)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Change in unrealized loss on investments, net of tax	36
Net loss	(153,606)
Ending balance (in shares) at Sep. 30, 2024		131,160,842
Ending balance at Sep. 30, 2024	189,504	$ 2	834,417	21	(644,936)
Beginning balance (in shares) at Mar. 31, 2024		120,021,274
Beginning balance at Mar. 31, 2024	243,766	$ 2	780,950	(95)	(537,091)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)		9,539
Issuance of common stock upon exercise of stock options	35		35
Stock-based compensation expense	8,091		8,091
Change in unrealized loss on investments, net of tax	24			24
Net loss	(55,327)				(55,327)
Ending balance (in shares) at Jun. 30, 2024		120,030,813
Ending balance at Jun. 30, 2024	196,589	$ 2	789,076	(71)	(592,418)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock (in shares)		11,006,163
Issuance of common stock	38,081		38,081
Issuances of common stock under the employee stock purchase plan (in shares)		115,021
Issuances of common stock under the employee stock purchase plan	401		401
Issuance of common stock upon exercise of stock options (in shares)		8,845
Issuance of common stock upon exercise of stock options	32		32
Stock-based compensation expense	6,827		6,827
Change in unrealized loss on investments, net of tax	92			92
Net loss	(52,518)				(52,518)
Ending balance (in shares) at Sep. 30, 2024		131,160,842
Ending balance at Sep. 30, 2024	$ 189,504	$ 2	834,417	21	(644,936)
Beginning balance (in shares) at Dec. 31, 2024	131,160,842	131,160,842
Beginning balance at Dec. 31, 2024	$ 153,149	$ 2	840,358	1	(687,212)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	5,681		5,681
Change in unrealized loss on investments, net of tax	(16)			(16)
Net loss	(51,890)				(51,890)
Ending balance (in shares) at Mar. 31, 2025		131,160,842
Ending balance at Mar. 31, 2025	$ 106,924	$ 2	846,039	(15)	(739,102)
Beginning balance (in shares) at Dec. 31, 2024	131,160,842	131,160,842
Beginning balance at Dec. 31, 2024	$ 153,149	$ 2	840,358	1	(687,212)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)	115,033
Change in unrealized loss on investments, net of tax	$ 32
Net loss	$ (155,063)
Ending balance (in shares) at Sep. 30, 2025	180,309,471	180,309,471
Ending balance at Sep. 30, 2025	$ 161,821	$ 2	1,004,061	33	(842,275)
Beginning balance (in shares) at Mar. 31, 2025		131,160,842
Beginning balance at Mar. 31, 2025	106,924	$ 2	846,039	(15)	(739,102)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of pre-funded warrants (in shares)		3,199,984
Issuances of common stock under the employee stock purchase plan (in shares)		133,612
Issuances of common stock under the employee stock purchase plan	197		197
Stock-based compensation expense	6,325		6,325
Change in unrealized loss on investments, net of tax	5			5
Net loss	(52,591)				(52,591)
Ending balance (in shares) at Jun. 30, 2025		134,494,438
Ending balance at Jun. 30, 2025	60,860	$ 2	852,561	(10)	(791,693)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock (in shares)		43,700,000
Issuance of common stock	138,380		138,380
Issuance of restricted stock units (in share)		2,000,000
Issuance of restricted stock units	0		0
Issuance of common stock upon exercise of stock options (in shares)		115,033
Issuance of common stock upon exercise of stock options	373		373
Stock-based compensation expense	12,747		12,747
Change in unrealized loss on investments, net of tax	43			43
Net loss	$ (50,582)				(50,582)
Ending balance (in shares) at Sep. 30, 2025	180,309,471	180,309,471
Ending balance at Sep. 30, 2025	$ 161,821	$ 2	$ 1,004,061	$ 33	$ (842,275)